KCNA3 and cardiovascular disorder: Potassium channels are involved in regulation of neurotransmission, heart rate, muscle contraction, hormone release, and cell survival, among others, and hence represent attractive drug targets for the development of new therapeutic strategies for cancer as well as metabolic, neurological, and cardiovascular disorders [23–27].